BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Update

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a significant decline in short interest in November. As of November 15th, there was short interest totalling 400 shares, a decline of 69.2% from the October 31st total of 1,300 shares. Based on an average trading volume of 4,000 shares, the short-interest ratio is currently 0.1 days.

BioSyent Price Performance

BIOYF traded up $0.02 during midday trading on Wednesday, reaching $8.05. The company’s stock had a trading volume of 520 shares, compared to its average volume of 2,237. The stock’s 50-day moving average is $8.03 and its 200-day moving average is $7.54. BioSyent has a 1 year low of $5.93 and a 1 year high of $8.90.

BioSyent Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be given a dividend of $0.0322 per share. This represents a yield of 1.6%. The ex-dividend date of this dividend is Friday, November 29th.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.